ATE1070T1 - Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff. - Google Patents

Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff.

Info

Publication number
ATE1070T1
ATE1070T1 AT79104763T AT79104763T ATE1070T1 AT E1070 T1 ATE1070 T1 AT E1070T1 AT 79104763 T AT79104763 T AT 79104763T AT 79104763 T AT79104763 T AT 79104763T AT E1070 T1 ATE1070 T1 AT E1070T1
Authority
AT
Austria
Prior art keywords
infectious peritonitis
virus
felids
preparation
vaccine containing
Prior art date
Application number
AT79104763T
Other languages
English (en)
Inventor
Bernarad Fishman
Kevin Joseph O'reilly
Louise Mary Hitchcock
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Application granted granted Critical
Publication of ATE1070T1 publication Critical patent/ATE1070T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT79104763T 1978-11-30 1979-11-29 Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff. ATE1070T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7846603 1978-11-30
EP19790104763 EP0011864B1 (de) 1978-11-30 1979-11-29 Abgeschwächter Stamm des bei Feliden infektiöse Peritonitis verursachenden Virus, Verfahren zu seiner Herstellung und ihn enthaltender Impfstoff

Publications (1)

Publication Number Publication Date
ATE1070T1 true ATE1070T1 (de) 1982-06-15

Family

ID=10501422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104763T ATE1070T1 (de) 1978-11-30 1979-11-29 Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff.

Country Status (11)

Country Link
US (1) US4571386A (de)
EP (1) EP0011864B1 (de)
JP (1) JPS5576819A (de)
AT (1) ATE1070T1 (de)
AU (1) AU5329279A (de)
DE (1) DE2962920D1 (de)
DK (1) DK507079A (de)
ES (1) ES8107025A1 (de)
HU (1) HU181993B (de)
NZ (1) NZ192270A (de)
ZA (1) ZA796476B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
AU604682B2 (en) * 1986-02-06 1991-01-03 Cornell Research Foundation Inc. Feline infectious peritonitis vaccine
US5043157A (en) * 1986-02-06 1991-08-27 Cornell Research Foundation, Inc. Feline infectious peritonitis vaccine and method of preparation
IL87911A0 (en) * 1987-10-01 1989-03-31 Norden Lab Inc Vaccine for protection of cats against feline infectious peritonitis
US5667785A (en) * 1987-10-01 1997-09-16 Pfizer Inc. Vaccine for protection of cats against feline infectious peritonitis
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
EP0627936A4 (de) * 1992-02-18 1997-01-02 Parhelion Corp Impfstoff gegen die infektiöse peritonitis bei katzen und methode seiner herstellung.
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
CN114874997B (zh) * 2022-05-26 2023-05-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猫杯状病毒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (de) * 1962-11-27
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
GB1286250A (en) * 1968-10-08 1972-08-23 Wellcome Found Heteroploid cell lines
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
GB1471262A (en) * 1974-03-25 1977-04-21 C Vet Ltd Virus growth
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
GB1492930A (en) * 1974-10-31 1977-11-23 Afg Ltd Virus growth
US3937812A (en) * 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines

Also Published As

Publication number Publication date
US4571386A (en) 1986-02-18
DK507079A (da) 1980-05-31
ZA796476B (en) 1981-07-29
NZ192270A (en) 1983-05-31
EP0011864A1 (de) 1980-06-11
EP0011864B1 (de) 1982-05-19
AU5329279A (en) 1980-06-05
HU181993B (en) 1983-11-28
DE2962920D1 (en) 1982-07-08
ES486442A0 (es) 1980-12-16
JPS5576819A (en) 1980-06-10
ES8107025A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
ATE1070T1 (de) Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff.
Yoshida Demonstration of serologically different capsular types among strains of Staphylococcus aureus by the serum-soft agar technique
ATE7855T1 (de) Herstellung von virusantigenen.
FR2602791B1 (fr) Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
AU8014691A (en) Vaccine against lyme disease and a challenge model for evaluating vaccine efficiency
ATE375T1 (de) Grippevirusimpfstoff und verfahren zu seiner herstellung.
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
EP0023731A3 (de) Verfahren zur Herstellung polyvalenter Virus-Impfstoffe in einem Einzelzellsystem, solche polyvalenten Impfstoffe und ihre Verwendung
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
ATE1044T1 (de) Impfstoff gegen infektioese peritonitis der feliden und verfahren zu seiner herstellung.
ATE14984T1 (de) Verfahren zur herstellung eines biochemischen vakzins gegen salmonellenfieber.
ATE18135T1 (de) Verfahren zur herstellung von einem verbessertem mutantenstamm von bordetella bronchiseptica und diesen enthaltendes lebendes attenuiertes vakzin.
US4213965A (en) Small-plaque variant canine herpesvirus vaccine
Hooker et al. Differentiation of Mycoplasma mycoides subsp. mycoides from certain closely related caprine mycoplasmas by mycoplasmaemia and cross-protection tests in mice
DE3779444T2 (de) Impfstoff gegen herpes simplex.
SU1520098A1 (ru) Способ получени иммуногенных вакцинных штаммов чумного микроба
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
RU93025043A (ru) Способ получения антигена против некробактериоза крупного рогатого скота
RU95101596A (ru) Штамм "м-92" инфекционной бурсальной болезни индеек - семейство birnoviridae

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee